1De sain - van der Velden MG, Kaysen GA, Barrett HA, et al. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int, 1998,53: 994-1001.
2Joven J, Villabona C, Vilella E, et al. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med,1990,323:579 - 584.
4Appel GB.Lipid abnormalities in renal disease. Kidney Int, 1991,39:169-183.
5Skrzep - poloczek B, Tomasik A, Tamawski R, et al. Nephrotic origin hyperlipilemia, relative reduction of Vitamin E level and consequent oxidative stress may promote atherosclerosis. Nephron, 2001,89:68 - 72.
6Warwick GL, Caslake MJ, Boulton - Jones JM, et al. Low - density lipoprote in metabolism in the nephrotic syndrome. Metabolism, 1990,39:187-192.
7Warwick GL, Packard CJ, Demant T, et al. Metabolism of apolipoprotein B-cxntaining lipoproteins in subjects with nephrotic - range proteinuria.Kidney Int, 1991,40:129 - 138.
8Gregory C, Shearer, Frazier T, et al, Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephroticsyndrome. Kidney Int,2001,59:179 - 189.
9Vaziri ND, Liang K. Downregulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int, 1996,50:887-893.
10Vaziri ND, Sato T, Liang K. Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis. Kidney Int, 2003, 63:1756-1763.
